Last reviewed · How we verify
Double dosage inactivated vaccine — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Double dosage inactivated vaccine (Double dosage inactivated vaccine) — Jiangsu Province Centers for Disease Control and Prevention.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Double dosage inactivated vaccine TARGET | Double dosage inactivated vaccine | Jiangsu Province Centers for Disease Control and Prevention | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Double dosage inactivated vaccine CI watch — RSS
- Double dosage inactivated vaccine CI watch — Atom
- Double dosage inactivated vaccine CI watch — JSON
- Double dosage inactivated vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Double dosage inactivated vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/double-dosage-inactivated-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab